Adam Harris is a corporate partner in our Tokyo office. He focuses his practice on cross-border mergers, acquisitions, disposals, spinouts, and joint ventures in various industries including life sciences, semiconductor-related businesses, heavy industries, and professional services.
Adam received his J.D. from Duke University School of Law, where he was a senior staff editor of the Duke Journal of Constitutional Law & Public Policy. He received his B.A. from University of North Carolina, Chapel Hill.
Adam has been recognized by The Best Lawyers in Japan in its Ones to Watch category for Capital Markets Law.
Adam is admitted to practice in Japan (Gaikokuho-Jimu-Bengoshi) and New York.
FormFactor’s partnership with MBK Partners to acquire FICT Limited
FormFactor, a leading provider of test and measurement technologies for the semiconductor industry, in its partnership with Asia-based private equity firm MBK Partners to acquire FICT Limited, a designer and manufacturer of high-end printed circuit boards (PCBs) and substrates from Asia-based private equity firm Advantage Partners.
Kyowa Kirin’s acquisition of Orchard Therapeutics
Kyowa Kirin, a Japanese pharma group, in its $360 million acquisition of Orchard Therapeutics plc, a company focused on treating severe genetic disorders.
Sekisui House’s acquisition of Chesmar Homes
Sekisui House, Ltd., a residential housing builder and developer, in its acquisition of Chesmar Homes, a leading developer of single-family homes in Texas, with operations in Houston, San Antonio, Austin, and Dallas-Fort Worth.
Sekisui House’s acquisition of Holt Group Inc.
Sekisui House, Ltd. in its acquisition of U.S. homebuilder Holt Group Inc., one of the largest private homebuilders and land developers in the U.S. Pacific Northwest.
Sekisui House’s acquisition of M.D.C. Holdings
Sekisui House, Ltd. in its $4.9 billion acquisition of M.D.C. Holdings, Inc., an NYSE listed company and the leading U.S. homebuilder operating under the Richmond American Homes brand.
Shinagawa Refractories’ carve-out acquisitions of Saint-Gobain’s Brazil and U.S. refractory businesses
Shinagawa Refractories, a listed Japanese manufacturer of refractory materials, in its simultaneous carve-out acquisitions of a Brazil refractory business and U.S. refractory business, both from Saint Gobain.
GCA Corporation’s sale to Houlihan Lokey
GCA Corporation, a Tokyo-based premier global investment banking firm, in its approximately $591 million sale via tender offer to Houlihan Lokey, Inc.
Mitsubishi Heavy Industries’ acquisition of Bombardier’s regional jet program
Mitsubishi Heavy Industries, Ltd. in its $550 million carve-out acquisition of the regional jet program from Bombardier Inc., a global leader in the transportation industry.
Taisho Pharmaceutical’s acquisition of UPSA from Bristol-Myers Squibb
Taisho Pharmaceutical in its $1.6 billion acquisition of UPSA, a French-based pharmaceutical products manufacturer with operations in over 50 countries throughout Europe and Africa, from Bristol-Myers Squibb.
L Catterton’s strategic investment in Ci FLAVORS
L Catterton, the largest global consumer-focused private equity firm, in its strategic investment in Ci FLAVORS, the holding entity for Cosme Company, a leading multi-brand beauty and personal care company in Japan focused on haircare and skincare.
Renesas Electronics’ acquisition of Steradian Semiconductors
Renesas Electronics Corporation in its acquisition of Steradian Semiconductors Private Limited, a fabless semiconductor company based in Bengaluru, India, that provides 4D imaging radar solutions, in an all-cash transaction.
TDK Corporation and Amperex Technologies’ business alliance with Contemporary Amperex Technology
TDK Corporation and TDK’s Hong Kong subsidiary, Amperex Technologies Limited, a leader in the rechargeable battery business, in a business alliance with Contemporary Amperex Technology Co. Limited, a publicly traded company in China with the world’s largest energy-vehicle battery business.